CrisnatolAlternative Names: 770U82; BW 770; BW 77OU82; BW A770U; Crisnatol mesylate
Latest Information Update: 17 Jun 2002
At a glance
- Originator Cancer Therapy and Research Center; Sanofi Winthrop
- Developer ILEX Oncology Inc
- Class Antineoplastics; Chrysenes; Propylene glycols; Small molecules
- Mechanism of Action DNA inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Glioma; Solid tumours